Bell Rock Capital’s GSK GSK Stock Holding History

Bell Rock Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-276	Closed	-$16K	–	154
2019 Q4	$16K	Hold	276	–	–	0.01%	291
2019 Q3	$14K	Buy	276 +3	+1%	+$154	0.01%	287
2019 Q2	$13K	Buy	273 +3	+1%	+$151	0.01%	291
2019 Q1	$14K	Sell	270 -530	-66%	-$26.5K	0.01%	326
2018 Q4	$38K	Hold	800	–	–	0.03%	251
2018 Q3	$40K	Hold	800	–	–	0.02%	261
2018 Q2	$40K	Hold	800	–	–	0.02%	269
2018 Q1	$39K	Hold	800	–	–	0.02%	269
2017 Q4	$35K	Hold	800	–	–	0.02%	266
2017 Q3	$41K	Hold	800	–	–	0.02%	248
2017 Q2	$43K	Hold	800	–	–	0.03%	240
2017 Q1	$42K	Buy	800 +509	+175%	+$25.8K	0.04%	207
2016 Q4	$14K	Buy	+291	New	+$14.4K	0.01%	272

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bell Rock Capital's GSK Position: Q1 2020 in Review

Bell Rock Capital sold out of GSK (GSK) in Q1 2020, closing a stake of 276 shares — an estimated $16K sold.

Bell Rock Capital first reported a position in GSK in Q4 2016 and held it in 13 quarters. The position peaked at $43K in Q2 2017. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

Bell Rock Capital reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
Bell Rock Capital sold 276 GSK shares in Q1 2020, an estimated $16K.
Bell Rock Capital first reported a position in GSK in Q4 2016 and held it in 13 quarters.
Bell Rock Capital's GSK position peaked at $43K in Q2 2017.
817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on Bell Rock Capital's 13F filing for Q1 2020, filed 7 May 2020.